We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Savient Secures Last-Minute Generic Oxandrin Ban

Law360 (December 13, 2006, 12:00 AM EST) -- Drug maker Savient Pharmaceuticals Inc. was able to buy more time for its weight-gain treatment Oxandrin Tuesday when it persuaded a U.S. federal appeals court at the last minute to issue...
To view the full article, register now.